Joseph Ciaffoni
Vermögen: 32 Mio $ am 30.06.2026
Vermögen: 32 Mio $ am 30.06.2026
Mr. Joseph J.
Ciaffoni is a Chief Executive Officer & Director at Indivior Pharmaceuticals, Inc. and a Chief Executive Officer & Director at Indivior Ltd. He is on the Board of Directors at Indivior Pharmaceuticals, Inc. and Indivior Ltd. Mr. Ciaffoni was previously employed as a President & Chief Executive Officer by BioDelivery Sciences International, Inc., a President & Chief Executive Officer by Collegium Pharmaceutical, Inc., a President-US Branded Pharmaceuticals by Endo International Plc, a Senior VP-Global Specialty Medicines Group by Biogen-Idec Pharmaceuticals, Inc., a Chief Commercial Officer & Executive VP by Shionogi Pharma, Inc., a Chief Operating Officer & Executive VP by Shionogi, Inc., and a Vice President-Sales by Schering-Plough Corp.
He received his undergraduate degree from Rutgers State University of New Jersey and an MBA from Rutgers State University of New Jersey.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0.65% | 22.06.2026 | 790’330 ( 0.65% ) | 32 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Indivior Ltd.
Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Vorstandsvorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Vorstandsvorsitzender | 24.05.2024 |
| ENDO INTERNATIONAL PLC | Corporate Officer/Principal | 01.12.2016 |
Biogen-Idec Pharmaceuticals, Inc.
Biogen-Idec Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.07.2016 |
Shionogi Pharma, Inc.
Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01.10.2010 |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Geschäftsführer | 01.10.2010 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
Shionogi Pharma, Inc.
Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures immunology, urology, hepatology, generics & sterile injectables therapeutics products | Health Technology |
Indivior Ltd.
Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Health Technology |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Health Technology |
Biogen-Idec Pharmaceuticals, Inc.
Biogen-Idec Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen